Celldex Therapeutics Inc (NASDAQ: CLDX) stock closed at $29.35 on 11/6/23 after a major increase of 13.0%. Relative to the market the stock has been weak over the last nine months but has risen 29.8% […]
OptimizeRX Corp (NASDAQ: OPRX) has reported E.P.S. of $-0.17 for its third fiscal quarter (ending September 30) versus $-0.19 for the same period a year ago. This performance was $-0.21 short of the consensus estimate […]
Myriad Genetics Inc (NASDAQ: MYGN) has reported E.P.S. of $-0.75 for its third fiscal quarter (ending September 30) versus $-0.43 for the same period a year ago. Relative to the consensus estimate of $-0.08, this […]
Idaho Strategic Resources Inc (NYSEAMERICAN: IDR) has reported E.P.S. of $0.03 for its third fiscal quarter (ending September 30) versus $-0.16 for the same period a year ago. For the latest four quarters through September […]
MagnaChip Semiconductor Corp (NYSE: MX) has reported E.P.S. of $-0.13 for its third fiscal quarter (ending September 30) versus $-0.38 for the same period a year ago. Relative to the consensus estimate of $-0.17, this […]
On 11/2/23, SunPower Corp (NASDAQ: SPWR) stock enjoyed a major increase of 10.9%, closing at $4.47. Relative to the market the stock has been extremely weak over the last nine months but has risen 10.1% […]
FARO Technologies Inc (NASDAQ: FARO) stock closed at $14.61 on 11/2/23 after a major increase of 15.9%. The stock has risen 10.7% during the last week but has been extremely weak relative to the market […]
The AES Corp (NYSE: AES) has reported E.P.S. of $0.34 for its third fiscal quarter (ending September 30) versus $0.63 for the same period a year ago — a decline of -46%. Relative to the […]
For its third fiscal quarter (ending September 30), Celldex Therapeutics Inc (NASDAQ: CLDX) has reported E.P.S. of $-0.81 compared to $-0.57 a year ago. This performance was $-0.15 short of the consensus estimate of $-0.66. […]
Intevac Inc (NASDAQ: IVAC) stock closed at $3.48 on 11/2/23 after a major increase of 11.5%. The stock has been extremely weak relative to the market over the last nine months but has risen 9.4% […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research